Self-evaluations of antidepressants
Copyright policy )Self-evaluations of antidepressants
Antidepressant clinical drug trials conducted from 1955–1972 are analyzed to determine the most frequently used patient self-rating scales and to estimate their relative sensitivities (validities). Other analyses suggest how the methodology of the trials may have influenced measurement sensitivity. Interpretive problems are discussed, and some tentative recommendations are presented.
- Boston College United States
- Boston University United States
Psychiatric Status Rating Scales, Clinical Trials as Topic, Imipramine, Psychological Tests, Dextroamphetamine, Diazepam, Depression, Amitriptyline, Desipramine, Chlordiazepoxide, Antidepressive Agents, Placebos, Pargyline, MMPI, Nialamide, Methylphenidate, Drug Evaluation, Humans, Drug Therapy, Combination, Doxepin
Psychiatric Status Rating Scales, Clinical Trials as Topic, Imipramine, Psychological Tests, Dextroamphetamine, Diazepam, Depression, Amitriptyline, Desipramine, Chlordiazepoxide, Antidepressive Agents, Placebos, Pargyline, MMPI, Nialamide, Methylphenidate, Drug Evaluation, Humans, Drug Therapy, Combination, Doxepin
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).39 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 1% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!